World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
33322
World Ranking
9315
National Ranking
4805

Overview

Christopher H. Crane is primarily affiliated with Memorial Sloan Kettering Cancer Center in the United States. Their research contributions span extensively across the field of medicine, with a significant focus on oncology. The subfields within their work include oncology, surgery, pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and radiation.

Their recent publication record demonstrates active engagement in clinical and translational cancer research. Notable recent papers include:

  • PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer, 2022, New England Journal of Medicine
  • Metastatic Pancreatic Cancer: ASCO Guideline Update, 2020, Journal of Clinical Oncology
  • Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer, 2021, JAMA Oncology
  • Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis, 2020, Cancer
  • Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer, 2021, Clinical Cancer Research

Frequent co-authors collaborating with Christopher H. Crane include:

  • Paul B. Romesser
  • Marsha Reyngold
  • Carla Hajj
  • Abraham J. Wu
  • Martin R. Weiser

Their work has been published primarily in a range of journals, with the most frequent venues being:

  • Cancer
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Clinical Oncology
  • Cancers
  • Advances in Radiation Oncology

The main research topics that characterize Christopher H. Crane's scientific contributions cover:

  • Colorectal and Anal Carcinomas
  • Pancreatic and Hepatic Oncology Research
  • Advanced Radiotherapy Techniques
  • Colorectal Cancer Surgical Treatments
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Genomics and Diagnostics
  • Gastric Cancer Management and Outcomes

Their research profile reflects a focus on both clinical treatment strategies and cancer biology, especially pertaining to colorectal, pancreatic, hepatic, and gastric malignancies. The frequent engagement with advanced radiotherapy techniques also indicates a specialization in improving therapeutic approaches within oncology.

Best Publications

  • Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

    Gauri R. Varadhachary;Eric P. Tamm;James L. Abbruzzese;Henry Q. Xiong

  • Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

    Patrick J. Loehrer;Yang Feng;Higinia Cardenes;Lynne Wagner

  • Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

    Matthew H.G. Katz;Peter W.T. Pisters;Douglas B. Evans;Charlotte C. Sun

  • Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

    Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun

  • Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

    Chandrajit P. Raut;Jennifer F. Tseng;Jennifer F. Tseng;Charlotte C. Sun;Huamin Wang

  • Pancreaticoduodenectomy with vascular resection: margin status and survival duration

    Jennifer F. Tseng;Chandrajit P. Raut;Jeffrey E. Lee;Peter W.T. Pisters

  • Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma

    Matthew Harold Katz;Matthew Harold Katz;Huamin Wang;Jason B Fleming;Charlotte C Sun

  • Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

    Matthew Harold Katz;Jason B Fleming;Priya R Bhosale;Gauri R Varadhachary

  • Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response

    Jaffer A. Ajani;Kathryn Winter;Gordon S. Okawara;John H. Donohue

  • Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

    Gauri R. Varadhachary;Robert A. Wolff;Christopher H. Crane;Charlotte C. Sun

  • Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

    Andrea Cercek;Campbell S.D. Roxburgh;Campbell S.D. Roxburgh;Paul Strombom;J. Joshua Smith

  • Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer

    In Ja Park;Y. Nancy You;Atin Agarwal;John M. Skibber

  • Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

    Theodore S. Hong;Jennifer Y. Wo;Beow Y. Yeap;Edgar Ben-Josef

  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.

    T. M. Breslin;K. R. Hess;D. B. Harbison;M. E. Jean

  • Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

    J. Joshua Smith;Paul Strombom;Oliver S. Chow;Campbell S. Roxburgh;Campbell S. Roxburgh

  • Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

    Chaitanya R. Churi;Rachna Shroff;Ying Wang;Asif Rashid

  • Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.

    Prajnan Das;John M. Skibber;Miguel A. Rodriguez-Bigas;Barry W. Feig

  • Hilar Cholangiocarcinoma: expert consensus statement

    John C. Mansour;Thomas A. Aloia;Christopher H. Crane;Julie K. Heimbach

  • Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.

    Rachna T. Shroff;Erin B. Kennedy;Melinda Bachini;Tanios Bekaii-Saab

  • Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation of Smad4(Dpc4) Immunostaining With Pattern of Disease Progression

    Christopher H. Crane;Gauri R. Varadhachary;John S. Yordy;Gregg A. Staerkel

Frequent Co-Authors

Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Sunil Krishnan
Sunil Krishnan The University of Texas MD Anderson Cancer Center
John M. Skibber
John M. Skibber The University of Texas MD Anderson Cancer Center
Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
Cathy Eng
Cathy Eng Vanderbilt University
Miguel A. Rodriguez-Bigas
Miguel A. Rodriguez-Bigas The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Jason B. Fleming
Jason B. Fleming The University of Texas MD Anderson Cancer Center
George J. Chang
George J. Chang The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Medicine in the USA opens doors to diverse healthcare career paths that extend well beyond the traditional MD. Many students consider practical alternatives such as lpn program options, which offer fast-track entry into nursing and patient care through online learning. For those already holding advanced degrees, the fastest post master's pmhnp programs provide an accelerated route to specialize in psychiatric-mental health as a nurse practitioner.

If you’re interested in healthcare leadership or operations, consider earning a bachelors in healthcare administration for foundational skills in managing healthcare organizations. Those looking to advance further in this field may benefit from cheapest mha programs online, which deliver essential business and managerial training at an affordable cost.

Whether your interests lie in clinical, mental health, or administrative roles, these pathways offer flexible online options for advancing your career in healthcare.

Best Scientists Citing Christopher H. Crane

Trending Scientists

Recently Published Articles